Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready
Carmel Haifa University Economic Corporation Ltd. operates in the Biotechnology & Pharmaceuticals technology area with 5 pending office actions. These actions are spread across 3 distinct art units. This indicates that the company's filings are reviewed by several different specialized groups within the patent office. The prosecution involves 5 distinct examiners.
BEAN, JARED C is the busiest examiner for this portfolio, currently overseeing 1 busiest examiner pending office action. This 1 busiest examiner pending office action is a small part of the total workload. The number of 5 distinct examiners matches the number of pending office actions, which means each case is likely handled by a different individual. The Biotechnology & Pharmaceuticals technology area is the primary focus for these matters.
Practitioners should observe that BEAN, JARED C is the busiest examiner despite having only a small pending workload. This suggests an even distribution of cases among the distinct examiners. With 3 distinct art units involved, the company's intellectual property strategy is spread across several technical niches within the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 1 (20%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BEAN, JARED C | 1 | 63.0% | +42.4% |
| SEAMAN, D MARGARET M | 1 | 76.5% | +8.0% |
| WANG, CHANG YU | 1 | 33.5% | +53.5% |
| NEGIN, RUSSELL SCOTT | 1 | 55.9% | +34.2% |
| MCMILLIAN, KARA RENITA | 1 | 30.7% | +37.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19135405 | AUTONOMOUS NAVIGATION IN UNKNOWN SPACES | BEAN, JARED C | — |
| 18433660 | COMPOSITIONS AND METHODS FOR DELIVERY AND EXPRESSION OF SMALL INHIBITORY PEPTIDES AND USE THEREOF | WANG, CHANG YU | — |
| 18566753 | SYSTEM AND METHOD FOR ASSESSING CONCENTRATION OF MOLECULES CONTAINING PROTEIN IN ALGAE BASED ON SPECTRAL MEASUREMENTS | NEGIN, RUSSELL SCOTT | — |
| 18284840 | NOVEL SULFONAMIDE SERIES OF QR2 INHIBITORS TO TACKLE OXIDATIVE STRESS AND COGNITIVE DECLINE | MCMILLIAN, KARA RENITA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19135405 | AUTONOMOUS NAVIGATION IN UNKNOWN SPACES | BEAN, JARED C | — |
| 18433660 | COMPOSITIONS AND METHODS FOR DELIVERY AND EXPRESSION OF SMALL INHIBITORY PEPTIDES AND USE THEREOF | WANG, CHANG YU | — |
| 18566753 | SYSTEM AND METHOD FOR ASSESSING CONCENTRATION OF MOLECULES CONTAINING PROTEIN IN ALGAE BASED ON SPECTRAL MEASUREMENTS | NEGIN, RUSSELL SCOTT | — |
| 18284840 | NOVEL SULFONAMIDE SERIES OF QR2 INHIBITORS TO TACKLE OXIDATIVE STRESS AND COGNITIVE DECLINE | MCMILLIAN, KARA RENITA | — |
| Art Unit | Apps |
|---|---|
| 3669 | 1 |
| 1649 | 1 |
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19135405 | AUTONOMOUS NAVIGATION IN UNKNOWN SPACES | BEAN, JARED C | 3669 | §102§103§112 | Non-Final OA | — | Pending | Jun 04, 2025 |
| 18863244 | STING INHIBITORS AND USE THEREOF | SEAMAN, D MARGARET M | — | §103 | Non-Final OA | — | Pending | Nov 05, 2024 |
| 18433660 | COMPOSITIONS AND METHODS FOR DELIVERY AND EXPRESSION OF SMALL INHIBITORY PEPTIDES AND USE THEREOF | WANG, CHANG YU | 1649 | §102§103§112Other | Non-Final OA | — | Pending | Feb 06, 2024 |
| 18566753 | SYSTEM AND METHOD FOR ASSESSING CONCENTRATION OF MOLECULES CONTAINING PROTEIN IN ALGAE BASED ON SPECTRAL MEASUREMENTS | NEGIN, RUSSELL SCOTT | — | §101§102§103§112 | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18284840 | NOVEL SULFONAMIDE SERIES OF QR2 INHIBITORS TO TACKLE OXIDATIVE STRESS AND COGNITIVE DECLINE | MCMILLIAN, KARA RENITA | 1623 | §103§112 | Non-Final OA | — | Pending | Sep 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial